Optimal endpoints in NAFLD clinical trials - Histology or non-invasive biomarkers and imaging?

 Metabolism, alcohol and toxicity

Room 3
English
Interactive Session
27 August 2020 17:00 - 18:00


Presentations

Title Time

Add to Calendar

Introduction
27 August 2020 17:00 - 17:04
Clinical trials outcomes: relevance to patients’ prognosis
27 August 2020 17:04 - 17:16
Non-invasive outcomes: which ones and when
27 August 2020 17:16 - 17:28
Histological outcomes: why is it still key
27 August 2020 17:28 - 17:40
Discussion, Q&A
27 August 2020 17:40 - 18:00